Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
EPZM

Epizyme

$12.75

-0.05 (-0.39%)

06:59
11/16/17
11/16
06:59
11/16/17
06:59
Hot Stocks
Epizyme treatment of follicular lymphoma granted FDA orphan status »

Epizyme's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

Over a week ago
EPZM

Epizyme

$13.65

-0.25 (-1.80%)

04:55
11/09/17
11/09
04:55
11/09/17
04:55
Conference/Events
Epizyme management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$13.90

-0.35 (-2.46%)

10:49
11/08/17
11/08
10:49
11/08/17
10:49
Conference/Events
Epizyme management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$16.15

-0.55 (-3.29%)

08:53
11/02/17
11/02
08:53
11/02/17
08:53
Recommendations
Epizyme analyst commentary at Leerink »

Epizyme price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$16.15

-0.55 (-3.29%)

07:54
11/02/17
11/02
07:54
11/02/17
07:54
Downgrade
Epizyme rating change at RBC Capital »

Epizyme downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$16.15

-0.55 (-3.29%)

06:17
11/02/17
11/02
06:17
11/02/17
06:17
Downgrade
Epizyme rating change at RBC Capital »

Epizyme downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$16.15

-0.55 (-3.29%)

16:24
11/01/17
11/01
16:24
11/01/17
16:24
Hot Stocks
Breaking Hot Stocks news story on Epizyme »

Epizyme sees cash and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 09

    Nov

  • 15

    Nov

EPZM

Epizyme

$16.15

-0.55 (-3.29%)

16:23
11/01/17
11/01
16:23
11/01/17
16:23
Earnings
Epizyme reports Q3 EPS (63c), consensus (65c) »

There was no revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 09

    Nov

  • 15

    Nov

Over a month ago
FGEN

FibroGen

$51.95

1.45 (2.87%)

, AUPH

Aurinia Pharmaceuticals

$6.26

0.15 (2.46%)

04:55
09/28/17
09/28
04:55
09/28/17
04:55
Conference/Events
Leerink to hold a roundtable »

RARE Disease &…

FGEN

FibroGen

$51.95

1.45 (2.87%)

AUPH

Aurinia Pharmaceuticals

$6.26

0.15 (2.46%)

EPZM

Epizyme

$17.25

0.85 (5.18%)

SELB

Selecta Biosciences

$19.38

0.72 (3.86%)

ALXN

Alexion

$139.45

-0.25 (-0.18%)

INSM

Insmed

$29.58

1.47 (5.23%)

DOVA

Dova Pharmaceuticals

$24.47

0.4 (1.66%)

EARS

Auris Medical

$0.73

-0.0004 (-0.05%)

ACHN

Achillion

$4.37

0.3 (7.37%)

CDTX

Cidara Therapeutics

$7.95

-0.1 (-1.24%)

VRTX

Vertex

$149.07

0.61 (0.41%)

BOLD

Audentes Therapeutics

$29.97

0.5 (1.70%)

WVE

Wave Life Sciences

$23.25

1.5 (6.90%)

EDGE

Edge Therapeutics

$10.61

0.76 (7.72%)

PRQR

ProQR Therapeutics

$5.15

-0.05 (-0.96%)

CBAY

CymaBay

$8.03

0.33 (4.29%)

QURE

uniQure

$8.78

-0.02 (-0.23%)

SCMP

Sucampo

$11.70

-0.05 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 23

    Oct

FGEN

FibroGen

$50.50

-1.25 (-2.42%)

, AUPH

Aurinia Pharmaceuticals

$6.11

-0.07 (-1.13%)

08:34
09/27/17
09/27
08:34
09/27/17
08:34
Conference/Events
Leerink to hold a roundtable »

RARE Disease &…

FGEN

FibroGen

$50.50

-1.25 (-2.42%)

AUPH

Aurinia Pharmaceuticals

$6.11

-0.07 (-1.13%)

EPZM

Epizyme

$16.40

-0.1 (-0.61%)

SELB

Selecta Biosciences

$18.66

-0.18 (-0.96%)

ALXN

Alexion

$139.70

-4.26 (-2.96%)

INSM

Insmed

$28.11

-0.31 (-1.09%)

DOVA

Dova Pharmaceuticals

$24.07

1.62 (7.22%)

EARS

Auris Medical

$0.73

-0.06 (-7.59%)

ACHN

Achillion

$4.07

-0.12 (-2.86%)

CDTX

Cidara Therapeutics

$8.05

0.2 (2.55%)

VRTX

Vertex

$148.46

-0.64 (-0.43%)

BOLD

Audentes Therapeutics

$29.47

0.65 (2.26%)

WVE

Wave Life Sciences

$21.75

-0.4 (-1.81%)

EDGE

Edge Therapeutics

$9.85

0.16 (1.65%)

PRQR

ProQR Therapeutics

$5.20

-1.25 (-19.38%)

CBAY

CymaBay

$7.70

-0.34 (-4.23%)

QURE

uniQure

$8.80

-0.3 (-3.30%)

SCMP

Sucampo

$11.75

-0.1 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.